[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.

Saved in:
Bibliographic Details
Title: [18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.
Authors: Jani AB; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA. Electronic address: abjani@emory.edu., Dhere VR; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Goyal S; Biostatistics Shared Resource, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Schreibmann E; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Patel PR; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Hershatter B; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Shelton JW; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Hanasoge S; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Sebastian NT; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Patel SA; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Halkar R; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Cooper S; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Fielder B; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Abiodun-Ojo OA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Lawal I; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Mushtaq A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Master VA; Department of Urology, Emory University, Atlanta, GA, USA., Joshi SS; Department of Urology, Emory University, Atlanta, GA, USA., Kucuk O; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Schuster DM; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
Source: European urology [Eur Urol] 2026 Apr; Vol. 89 (4), pp. 368-377. Date of Electronic Publication: 2025 Dec 17.
Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2025.12.003